Firefly Neuroscience, Inc. - Multiplikator nilai perusahaan marang pendapatan AIFF

The EV/Sales chart illustrates the business valuation relative to revenue, where the value has stabilized at 2233.01. Firefly Neuroscience, Inc (AIFF) utilizes AI for the diagnosis of dementia and autism via EEG, leveraging licenses from clinics and pharmaceutical companies. Patents and FDA certification create a defensive barrier, while high digital scalability of the software given current market volumes establishes potential for future growth.
AIFF (Firefly Neuro): rincian analitis lan laporan miturut indikator

Firefly Neuroscience, Inc (AIFF) is implementing AI diagnostics for mental disorders, creating sustainable demand from clinics, which makes the EV/Sales ratio a key indicator of technology monetization efficiency. This multiple compares the total enterprise value, adjusted for net debt, against annual revenue, allowing investors to determine the degree of asset overvaluation relative to actual sales volumes.